Cost-Effectiveness of Direct Non-Vitamin K Oral Anticoagulants Versus Vitamin K Antagonists for the Management of Patients with Non-Valvular Atrial Fibrillation Based on Available “Real-World” Evidence: The Italian National Health System Perspective

BACKGROUND AND OBJECTIVE: The increasing availability of real-world evidence (RWE) about safety and effectiveness of direct non-vitamin K oral anticoagulants (DOACs) for the management of atrial fibrillation (AF) offers the opportunity to better understand the clinical and economic implications of D...

Descripción completa

Detalles Bibliográficos
Autores principales: Lorenzoni, Valentina, Pirri, Salvatore, Turchetti, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946694/
https://www.ncbi.nlm.nih.gov/pubmed/33587284
http://dx.doi.org/10.1007/s40261-021-01002-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946694/
https://www.ncbi.nlm.nih.gov/pubmed/33587284
http://dx.doi.org/10.1007/s40261-021-01002-z

Ejemplares similares